Delivery Order SPE2DR25D2005-SPE2DR26FE8L5
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,953.12 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injectors on November 24, 2025, with an ultimate completion date of November 25, 2025. This contract utilizes firm fixed pricing with no set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be delivered to AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,059.05 to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitive award to support federal pharmaceutical procurement needs. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with a completion date of December 2, 2025....
- The Defense Logistics Agency awarded a $3,684.57 delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections, with completion targeted for November 14, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The product will be delivered to the company's headquarters location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections with a ceiling value of $77,518.39. This firm fixed-price delivery order, with an ultimate completion date of November 26, 2025, was competitively awarded with no set-aside designation. The pharmaceutical product will be sourced from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $12,150.18 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 ml pen injections on November 17, 2025. This non-set-aside, competitively awarded contract represents a firm fixed price delivery order with an ultimate completion date of November 18, 2025. The pharmaceutical product will be delivered to the contracting location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a $27,216.21 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 mL pen injections, with an ultimate completion date of September 22, 2025. This non-set-aside delivery order was competitively awarded and represents a single transaction under AmerisourceBergen's existing contract vehicles supporting federal pharmaceutical procurement. The product will be delivered to the company's Conshohocken, Pennsylvania facility, where...
- The Defense Logistics Agency awarded a delivery order valued at $6,148.98 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections. This is a firm fixed-price contract with no set-aside designation, classified as a competitive delivery order under the company's broader pharmaceutical supply agreements. Performance will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 14,...
- The Defense Logistics Agency awarded a delivery order valued at $23,545.58 to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of September 16, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for $3,431.61 on August 21, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injectors. This firm fixed-price, non-set-aside delivery order is scheduled for completion by August 22, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value transaction under AmerisourceBergen's larger relationship...
- The Defense Logistics Agency awarded a delivery order valued at $23,037.93 to AmerisourceBergen Drug Corp for the supply of Zepbound 15 mg/0.5 ml pen injections on November 10, 2025. This is a firm fixed price contract with an ultimate completion date of November 12, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's capability to compete...
- SPE2DR25D2005Indefinite Delivery Contract
- SPE2DR25D2005-SPE2DR26FE8L5Delivery Order
The Defense Logistics Agency (DLA) awarded a $13,313.09 delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections, with an ultimate completion date of December 10, 2025. This is a firm fixed price contract with no set-aside designation, meaning it was competitively awarded. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor serving federal healthcare systems. This delivery order is a child contract issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contracting portfolio demonstrates extensive experience fulfilling DLA medical procurement requirements across multiple therapeutic domains, positioning the company as a critical vendor for military and veteran healthcare systems in delivering both brand-name and generic medications.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.3k | 12/8/25 |